London, Uk-based CBPE Capital has sold Rosemont Pharmaceuticals to Perrigo Company, the $10 billion US listed pharmaceuticals business. CBPE acquired Rosemont in August 2006. The sale to Perrigo represents an investment multiple of 3.25x.
You are browsing the archive for CBPE Capital - peHUB.
CBPE Capital, a UK-based mid-market private equity firm, has closed its eighth fund with £405 million in capital commitments. The frim began fundraising in Q4 2008, and held a £270 million first close last April. Its seventh fund closed on £360 million in 2004.
CBPE Capital, a UK mid-market private equity firm, has held a £270 million first close for its eighth fund, which already has over £300 million in commitments. A final close is expected later this year. Berchwood Partners is serving as placement agent.